Qube Research & Technologies (QRT)’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-54,808
| Closed | -$34.8K | – | 2806 |
|
|
2025
Q1 | $34.8K | Sell |
54,808
-300
| -0.5% | -$191 | ﹤0.01% | 2433 |
|
|
2024
Q4 | $56.8K | Hold |
55,108
| – | – | ﹤0.01% | 2364 |
|
|
2024
Q3 | $65K | Buy |
55,108
+500
| +0.9% | +$590 | ﹤0.01% | 2329 |
|
|
2024
Q2 | $66.6K | Sell |
54,608
-78,591
| -59% | -$95.9K | ﹤0.01% | 2315 |
|
|
2024
Q1 | $290K | Buy |
133,199
+132,940
| +51,328% | +$290K | ﹤0.01% | 2413 |
|
|
2023
Q4 | $401 | Hold |
259
| – | – | ﹤0.01% | 3503 |
|
|
2023
Q3 | $334 | Buy |
+259
| New | +$334 | ﹤0.01% | 3272 |
|
|
2023
Q2 | – | Sell |
-13,050
| Closed | -$19.7K | – | 2401 |
|
|
2023
Q1 | $19.7K | Sell |
13,050
-43,231
| -77% | -$65.3K | ﹤0.01% | 2249 |
|
|
2022
Q4 | $90.1K | Buy |
56,281
+5,695
| +11% | +$9.11K | ﹤0.01% | 1960 |
|
|
2022
Q3 | $73K | Sell |
50,586
-5,260
| -9% | -$7.59K | ﹤0.01% | 2012 |
|
|
2022
Q2 | $102K | Buy |
+55,846
| New | +$102K | ﹤0.01% | 1931 |
|
|
2021
Q3 | – | Sell |
-18,101
| Closed | -$115K | – | 2300 |
|
|
2021
Q2 | $115K | Buy |
+18,101
| New | +$115K | ﹤0.01% | 1916 |
|